logo
15:59 Apr 30

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
387.75
-12.60 (-3.15%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Hikal Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 15:59 Apr 30
Up
387.75
-12.60 (-3.15%)
image/svg+xml

59/100 High Financial Strength

Quality
image/svg+xml

27/100 Expensive Valuation

Valuation

57/100 Technically Neutral

Technical

SWOT

Strength

2

Weakness

10

Opportunity

0

Threat

0

4.78K

Market Cap (Cr)

64.11

PE Ratio

3.97

Price to Book Ratio

44.2

RSI

3.90 %

Net Profit Margin

Rating Based on 1 Analysts

Buy 100%
Hold 0%
Sell 0%
Buy
The consensus recommendation from 1 analysts for Hikal Ltd. is Buy

Analyst Price Target

The average price target is 420 with a high estimate of 420 and low estimate of 420
Current 387.75
420.00
420.00
420.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Research 360 logo

Download Our App On:

SunMonTueWedThuFriSat
2627282930311234567891011121314151617181920212223242526272829303112345